Opioid receptors are fantastic targets for treating pain—but unfortunately, the drugs that target them can be addictive. Because the molecules suppress breathing and heart function, those drugs can ...
Septerna has secured $150 million in a series B fundraise, money that will go toward two newly unveiled programs including moving its first G-protein-coupled receptor (GPCR) drug into the clinic. The ...
Class B G-protein-coupled receptors (GPCRs), which include the glucagon-like peptide 1 receptor (GLP1R) and parathyroid hormone receptor 1 (PTH1R), are peptide hormone receptors that represent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results